Pfizer offered to buy Medivation for $81.50/share in cash, yet the stock is trading at around $80.32 on Tuesday morning. Why not $81.50? The market is pricing in $0.18 of risk that the deal won't go through. Risk arbitrage traders scoop up shares of the target company and hold until they receive the full cash value of the buyout offer.